Product Information  
Product Name : Olmesartan Medoxomil
Other Name : Olmetec, Benicar, Olmesartan medoximil , Type-1 angiotensin II receptor, AT1 , AT1AR, CS-866, 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1h-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
CAS NO. : 144689-63-4
Molecular Formula : C29H30N6O6
Molecular Weight : 558.58
Structural Formula : Olmesartan Medoxomil, Olmetec, Benicar,  Olmesartan medoximil , Type-1 angiotensin II receptor, AT1 , AT1AR, CS-866, 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1h-tetazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
Specs : 98.5% (HPLC) White to off-white powder
Application :       Olmesartan Medoxomil, a specific angiotensin II type 1 antagonist, is used alone or with other antihypertensive agents to treat hypertension, controls high blood pressure. Unlike the angiotensin receptor antagonist losartan, olmesartan does not have an active metabolite or possess uricosuric effects.
       Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not overcome the effect of olmesartan on blood pressure.

 

 

NINGBO PANGS CHEM INT'L CO.,LTD
Lisa Luo (Sales Manager)

Tel:      0086-574-27666856
Fax:    0086-574-27668686 /27668810
Email:  lisaluo@china-pharma-partner.com
           zjuxiaoling@gmail.com
MSN:   zjuxiaoling@hotmail.com
Add:    FLOOR 21, BUILDING 11, XINTIANDI, NO.689,SHIJIROAD, NINGBO, CHINA 315040

 

 

NINGBO PANGS CHEM INT'L CO.,LTD
Lisa Luo (Sales Manager)

Tel:      0086-574-27666856
Fax:    0086-574-27668686 /27668810
Email:  lisaluo@china-pharma-partner.com
           zjuxiaoling@gmail.com
MSN:   zjuxiaoling@hotmail.com
Add:    FLOOR 21, BUILDING 11, XINTIANDI, NO.689,SHIJIROAD, NINGBO, CHINA 315040

 

 

  Copyright © 2000-2008 Ningbo Pangs Chem Int'l Co.,Ltd. All rights reserved.